Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Coeptis Therapeutics Holdings (COEP) EBT Margin (2021 - 2025)

Coeptis Therapeutics Holdings (COEP) has 2 years of EBT Margin data on record, last reported at 1220.84% in Q3 2025.

  • For Q3 2025, EBT Margin changed N/A year-over-year to 1220.84%; the TTM value through Sep 2025 reached 2727.78%, changed N/A, while the annual FY2021 figure was 17932.37%, N/A changed from the prior year.
  • EBT Margin reached 1220.84% in Q3 2025 per COEP's latest filing, up from 2159.94% in the prior quarter.
  • Across five years, EBT Margin topped out at 81.99% in Q4 2021 and bottomed at 5440.95% in Q1 2025.